antidiabetic drugs
The       antihyperglycemic effect of troglitazone as monotherapy is rather modest       (reduction of HbA1c by 0.5-1.0%), but it appears to be somewhat greater when it       is combined with other antidiabetic drugs.
The       antihyperglycemic effect of  @OBJECT$  as monotherapy is rather modest       (reduction of HbA1c by 0.5-1.0%), but it appears to be somewhat greater when it       is  @PREDICAT$  with other  @SUBJECT$ .